-
4701
Update on Biology of Cutaneous T-Cell Lymphoma
Published 2020-05-01“…Cutaneous T cell lymphomas (CTCL) comprise of a heterogeneous group of non-Hodgkin lymphomas derived from skin-homing T cells. Variation in clinical presentation and lack of definitive molecular markers make diagnosis especially challenging. …”
Get full text
Article -
4702
Dysregulation of Cell Survival in Diffuse Large B Cell Lymphoma: Mechanisms and Therapeutic Targets
Published 2019-03-01“…Diffuse large B cell lymphoma (DLBCL) is the most common type of lymphoma worldwide, representing 30–40% of non-Hodgkin lymphomas, and is clinically aggressive. Although more than half of patients with DLBCL are cured by using standard first-line immunochemotherapy, the remaining patients are refractory to the first-line therapy or relapse after complete remission and these patients require novel therapeutic approaches. …”
Get full text
Article -
4703
Bortezomib for the Treatment of Hematologic Malignancies: 15 Years Later
Published 2019-04-01“…Furthermore, continued clinical studies are required to confirm its value for patients with indolent and aggressive B-cell non-Hodgkin lymphomas and acute leukemias.…”
Get full text
Article -
4704
Extranodal Non-Hodgkin’s Lymphoma at Maxillofacial Bone: A Case Report
Published 2019-09-01“…Conclusion: Chemotherapy remains the treatment of choice for non-Hodgkin lymphomas. Surgery also takes place in modality choice of treatment of maxillary cancer, either a partial or total maxillectomy alone, or maxillectomy with craniofacial resection.…”
Get full text
Article -
4705
A Comparison of the Fifth World Health Organization and the International Consensus Classifications of Mature T-Cell Lymphomas
Published 2023-09-01“…Peripheral T-cell lymphomas (PTCLs) are a rare subset of non-Hodgkin lymphomas that often carry significant difficulty in diagnosis and classification because of their rarity and biological complexity. …”
Get full text
Article -
4706
Subcutaneous Panniculitis-Like T-Cell Lymphoma Presenting as a Local Inflammation of a Thigh in an 8-Month-Old Child
Published 2017-01-01“…Histopathological examination confirmed a subcutaneous panniculitis-like T-cell lymphoma, which is a rare cytotoxic T-cell lymphoma representing less than 1% of non-Hodgkin lymphomas, uncommon in children. The patient was introduced to a chemotherapy protocol EURO-LB 2002 with good response. …”
Get full text
Article -
4707
Primary Pulmonary B-Cell Lymphoma: A Review and Update
Published 2021-01-01“…Primary pulmonary B-cell lymphomas (PP-BCLs) comprise a group of extranodal non-Hodgkin lymphomas of B-cell origin, which primarily affect the lung without evidence of extrapulmonary disease at the time of diagnosis and up to 3 months afterwards. …”
Get full text
Article -
4708
Pulmonary extra‐nodal mucosa‐associated lymphoid tissue (MALT) lymphoma: A rare cause of persistent lung consolidation
Published 2023-08-01“…Abstract Pulmonary extra‐nodal marginal zone B‐cell lymphoma, also known as extra‐nodal mucosa‐associated lymphoid tissue (MALT) lymphoma, is rare among all non‐Hodgkin lymphomas and generally among all pulmonary malignancies. …”
Get full text
Article -
4709
Primary cutaneous B-cell lymphoma and chronic leg ulcers in a patient with type 2 diabetes
Published 2017-05-01“…After gastrointestinal tract, the skin is the second most frequent extranodal site involved by non-Hodgkin lymphomas and the cutaneous B-cell lymphomas (CBCLs) range from 25% to 30% of all primary cutaneous lymphomas. …”
Get full text
Article -
4710
RETROSPECTIVE STUDY REGARDING LYMPHOMAS OF THE PAROTID GLAND
Published 2015-01-01“…Results Parotid gland lymphomas represent about 5% of all parotid tumors and 13% of the malignant ones. 80% were non-Hodgkin lymphomas. The highest incidence was found in the age decades 31-40 and 41-50, predominantly in males. 80% of the parotid lymphomas were on the superficial lobe. …”
Get full text
Article -
4711
How molecular advances may improve the diagnosis and management of PTCL patients
Published 2023-06-01“…Peripheral T-cell lymphomas (PTCL) comprised more than 30 rare heterogeneous entities, representing 10 to 15% of adult non-Hodgkin lymphomas. Although their diagnosis is still mainly based on clinical, pathological, and phenotypic features, molecular studies have allowed for a better understanding of the oncogenic mechanisms involved and the refinement of many PTCL entities in the recently updated classifications. …”
Get full text
Article -
4712
Therapeutic options in peripheral T cell lymphoma
Published 2016-04-01“…Abstract Peripheral T cell lymphoma (PTCL) is a rare and heterogeneous group of non-Hodgkin lymphomas with a very poor prognosis. The standard first-line treatments have resulted in unsatisfactory patient outcomes. …”
Get full text
Article -
4713
Targeting ATM-deficient CLL through interference with DNA repair pathways
Published 2015-06-01“…Chronic lymphocytic leukemia (CLL) is the most common form of leukemia in the Western world and accounts for approximately 30% of adult leukemias and 25% of non-Hodgkin lymphomas. The median age at diagnosis is 72 years. …”
Get full text
Article -
4714
The angiogenic receptor KDR is widely distributed in human tissues and tumours and relocates intracellularly on phosphorylation. An immunohistochemical study.
Published 2003“…It was also present in a number of human tumours including breast carcinomas, colonic carcinomas and non-Hodgkin's lymphomas. The pattern of staining was membranous, cytoplasmic and nuclear. …”
Journal article -
4715
Pulmonary extra-nodal mucosa-associated lymphoid tissue (MALT) lymphoma: A rare cause of persistent lung consolidation
Published 2023“…Pulmonary extra-nodal marginal zone B-cell lymphoma, also known as extra-nodal mucosa-associated lymphoid tissue (MALT) lymphoma, is rare among all nonHodgkin lymphomas and generally among all pulmonary malignancies. …”
Get full text
Get full text
Article -
4716
-
4717
Investigation of canine extracellular vesicles in diffuse large B-cell lymphomas.
Published 2022-01-01“…The similar changes to the EV population in dogs, together with the similar pathological features and treatment protocols in canine and human non-Hodgkin lymphomas would make dogs a good comparative model for studying the role of EVs in DLBCL development and progression.…”
Get full text
Article -
4718
Female genital tract malignancies in a Niger- Delta region of Nigeria
Published 2013-02-01“…There were two cases of ovarian Non-Hodgkins lymphoma. Overall, the peak age at presentation was 40 -50 years, while the peak ages for cervical cancer, ovarian cancer and endometrial malignancies were 40-50years, 30-40years and 40-50years respectively. …”
Get full text
Article -
4719
Investigation of canine extracellular vesicles in diffuse large B-cell lymphomas
Published 2022-01-01“…The similar changes to the EV population in dogs, together with the similar pathological features and treatment protocols in canine and human non-Hodgkin lymphomas would make dogs a good comparative model for studying the role of EVs in DLBCL development and progression.…”
Get full text
Article -
4720
Apoptosis Induction and Gene Expression Profile Alterations of Cutaneous T-Cell Lymphoma Cells following Their Exposure to Bortezomib and Methotrexate.
Published 2017-01-01“…Mycosis fungoides (MF) and its leukemic variant Sézary syndrome (SS) comprise the majority of CTCL, a heterogenous group of non-Hodgkins lymphomas involving the skin. The CTCL's resistance to chemotherapy and the lack of full understanding of their pathogenesis request further investigation. …”
Get full text
Article